Avadel Pharmaceuticals Plc2025财年第一财季实现净利润-4.92百万美元，同比增加82.00%

市场透视2025-05-16

5月16日，Avadel Pharmaceuticals Plc（AVDL.US）公布财报，公告显示公司2025财年第一财季净利润为-4.92百万美元，同比增加82.00%；其中营业收入为52.51百万美元，同比增加93.19%，每股基本收益为-0.05美元。从资产负债表来看，Avadel Pharmaceuticals Plc（AVDL.US）总负债93.88百万美元，其中短期债务...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535873354?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-16 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535873354","market":"us","top_or_hot":-1,"title":"Avadel Pharmaceuticals Plc2025财年第一财季实现净利润-4.92百万美元，同比增加82.00%","media":"市场透视","content":"<div>\n<p>5月16日，Avadel Pharmaceuticals Plc（AVDL.US）公布财报，公告显示公司2025财年第一财季净利润为-4.92百万美元，同比增加82.00%；其中营业收入为52.51百万美元，同比增加93.19%，每股基本收益为-0.05美元。从资产负债表来看，Avadel Pharmaceuticals Plc（AVDL.US）总负债93.88百万美元，其中短期债务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000146a6e08e69&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avadel Pharmaceuticals Plc2025财年第一财季实现净利润-4.92百万美元，同比增加82.00%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvadel Pharmaceuticals Plc2025财年第一财季实现净利润-4.92百万美元，同比增加82.00%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-16 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000146a6e08e69&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月16日，Avadel Pharmaceuticals Plc（AVDL.US）公布财报，公告显示公司2025财年第一财季净利润为-4.92百万美元，同比增加82.00%；其中营业收入为52.51百万美元，同比增加93.19%，每股基本收益为-0.05美元。从资产负债表来看，Avadel Pharmaceuticals Plc（AVDL.US）总负债93.88百万美元，其中短期债务...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000146a6e08e69&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVDL","symbol_name":"Avadel Pharmaceuticals plc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000146a6e08e69&s=b","article_id":"2535873354","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516000146a6e08e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535873354","pubTimestamp":1747324842,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"5月16日，Avadel Pharmaceuticals Plc公布财报，公告显示公司2025财年第一财季净利润为-4.92百万美元，同比增加82.00%；其中营业收入为52.51百万美元，同比增加93.19%，每股基本收益为-0.05美元。从资产负债表来看，Avadel Pharmaceuticals Plc总负债93.88百万美元，其中短期债务706000.00美元，资产负债比为0.02，流动比率为0.03。机构评级：截至2025年5月16日，当前有10家机构对Avadel Pharmaceuticals Plc目标价做出预测，其中目标均价为17.90美元，其中最低目标价为13.00美元，最高目标价为22.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"AVDL":"Avadel Pharmaceuticals plc"},"translate_title":"Avadel Pharmaceuticals Plc achieved net profit of-US $4.92 million in the first fiscal quarter of fiscal year 2025, a year-on-year increase of 82.00%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVDL":0.9},"content_text":"5月16日，Avadel Pharmaceuticals Plc（AVDL.US）公布财报，公告显示公司2025财年第一财季净利润为-4.92百万美元，同比增加82.00%；其中营业收入为52.51百万美元，同比增加93.19%，每股基本收益为-0.05美元。从资产负债表来看，Avadel Pharmaceuticals Plc（AVDL.US）总负债93.88百万美元，其中短期债务706000.00美元，资产负债比为0.02，流动比率为0.03。机构评级：截至2025年5月16日，当前有10家机构对Avadel Pharmaceuticals Plc目标价做出预测，其中目标均价为17.90美元，其中最低目标价为13.00美元，最高目标价为22.00美元。公司简介：Avadel Pharmaceuticals PLC是一家专业制药公司。该公司致力于通过改变药物来改变人们的生活。它为开发能够解决患者当前治疗选择所面临挑战的药物提供解决方案。公司从事开发不同形式给药的差异化药品，例如胶囊、片剂、注射剂等。其商业化产品LUMRYZ是一种羟丁酸钠缓释制剂，适用于成人发作性睡病的猝倒或过度日间嗜睡的治疗，需在睡前服用一次。公司仅在一个部门运营，即医药产品的开发与商业化，包括基于其专有聚合物技术的控释治疗产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535873354","isCrawlerRequest":true}